Now showing items 1-8 of 8

    • Antimicrobial and anti-viral effects of selenium nanoparticles and selenoprotein based strategies: COVID-19 and beyond 

      Khurana, Amit; Allawadhi, Prince; Singh, Vishakha; Khurana, Isha; Yadav, Poonam; Sathua, Kshirod Bihari; Allwadhi, Sachin; Banothu, Anil Kumar; Navik, Umashanker; Bharani, Kala Kumar (Editions de Sante, 2023-06-08)
      Deficiency of selenium (Se) has been described in a significant number of COVID-19 patients having a higher incidence of mortality, which makes it a pertinent issue to be addressed clinically for effective management of ...
    • Can bilirubin nanomedicine become a hope for the management of COVID-19? 

      Khurana, Isha; Allawadhi, Prince; Khurana, Amit; Srivastava, Amit Kumar; Navik, Umashanker; Banothu, Anil Kumar; Bharani, Kala Kumar (Churchill Livingstone, 2021-02-15)
      Bilirubin has been proven to possess significant anti-inflammatory, antioxidant and antiviral activities. Recently, it has been postulated as a metabolic hormone. Further, moderately higher levels of bilirubin are positively ...
    • COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis 

      Bhattacharyya, Anusuya; Sarma, Phulen; Kaur, Hardeep; Kumar, Subodh; Bhattacharyya, Jaimini; Prajapat, Manisha; Prakash, Ajay; Sharma, Saurabh; Reddy, Dibbanti Harikrishna; Thota, Prasad; Bansal, Seema; Gautam, Bhaswati Sharma; Medhi, Bikash (Wolters Kluwer Medknow Publications, 2021-12-30)
      BACKGROUND: Till now, no meta-analysis is available to address the clinical profile, risk factors, different interventions, and outcomes among COVID-19-associated rhino-orbito-cerebral mucormycosis (C-ROCM) cases. MATERIALS ...
    • Currently available COVID-19 management options 

      Ludhiadch, Abhilash; Yadav, Umesh Prasad; Munshi, Anjana (Elsevier, 2023-01-20)
      The pandemic caused by new coronavirus (COVID-19), i.e., severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), started from the Wuhan state of China. COVID-19 is a novel infectious disease characterized by atypical ...
    • Decorin as a possible strategy for the amelioration of COVID-19 

      Allawadhi, Prince; Singh, Vishakha; Khurana, Isha; Rawat, Pushkar Singh; Renushe, Akshata Patangrao; Khurana, Amit; Navik, Umashanker; Allwadhi, Sachin; Kumar Karlapudi, Satish; Banothu, Anil Kumar; Bharani, Kala Kumar (Churchill Livingstone, 2021-05-20)
      Coronavirus pandemic has emerged as an extraordinary healthcare crisis in modern times. The SARS-CoV-2 novel coronavirus has high transmission rate, is more aggressive and virulent in comparison to previously known ...
    • Insight into the liver dysfunction in COVID-19 patients: Molecular mechanisms and possible therapeutic strategies 

      Khullar, Naina; Bhatti, Jasvinder Singh; Singh, Satwinder; Thukral, Bhawana; Hemachandra Reddy, P.; Bhatti, Gurjit Kaur (Baishideng Publishing Group Inc, 2023-04-12)
      As of June 2022, more than 530 million people worldwide have become ill with coronavirus disease 2019 (COVID-19). Although COVID-19 is most commonly associated with respiratory distress (severe acute respiratory syndrome), ...
    • Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review 

      Bhattacharyya, Anusuya; Sarma, Phulen; Sharma, Dibya; Das, Karuna; Kaur, Hardeep; Prajapat, Manisha; Kumar, Subodh; Bansal, Seema; Prakash, Ajay; Avti, Pramod; Thota, Prasad; Reddy, Dibbanti; Gautam, Bhaswati; Medhi, Bikash (Wolters Kluwer Medknow Publications, 2021-08-18)
      Since the onset of COVID-19 pandemic, parallel opportunistic infections have also been emerging as another disease spectrum. Among all these opportunistic infection, mucormycosis has become a matter of concern with its ...
    • Role of vitamins and minerals as immunity boosters in COVID-19 

      Kumar, Puneet; Kumar, Mandeep; Bedi, Onkar; Gupta, Manisha; Kumar, Sachin; Jaiswal, Gagandeep; Rahi, Vikrant; Yedke, Narhari Gangaram; Bijalwan, Anjali; Sharma, Shubham; Jamwal, Sumit (Springer Science and Business Media Deutschland GmbH, 2021-06-10)
      Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) known as coronavirus disease (COVID-19), emerged in Wuhan, China, in December 2019. On March 11, 2020, it was declared a global pandemic. As the world grapples ...